EXPLORE!

EMA panel recommends 3 month interval for Moderna booster jab

  665 Views

#Hospital Medicine  #Infectious Diseases  #Pathology and Lab Medicine  #Pharmacist  #Public Health  #Pulmonary Medicine 

eMediNexus    26 February 2022

The advisory committee to the European Union′s drug regulator has recommended reducing the interval between the second dose and booster jab of Moderna COVID-19 vaccine from six months to three months.

Many countries, including Greece and France, have already reduced the interval between the first two doses and the booster dose of COVID-19 vaccines, considering the increase in infections due to the Omicron variant. Some countries have also authorized a fourth dose for the vulnerable people.

The European Medicines Agency (EMA) had stated in December that data supported safe and effective use of a booster dose as early as three months after the two-dose primary series, without changing the recommendation of a six month gap. EMA′s Committee for Medicinal Products for Human Use (CHMP) has also recommended the use of Moderna′s vaccine, Spikevax, in children aged between 6 and 11 years… (Reuters, February 25, 2022)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.